CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:
Jefferies Healthcare Conference
Presentation date: Wednesday, June 8, 2022
Presentation time: 2:30 PM ET
Location: Marriott Marquis, New York, NY
Goldman Sachs 43rd Annual Global Healthcare Conference
Dates: June 13-16, 2022
1×1 meetings only
Location: Terranea Resort, Ranch Palos Verdes, CA
JMP Securities Life Sciences Conference
Fireside Chat date: Thursday, June 16, 2022
Presentation time: 11:00 AM ET
Location: The Lotte New York Palace Hotel, New York, NY
Stifel’s 2022 Virtual Cell Therapy Summit
Dates: June 29-30, 2022
Live webcasts and archived replays of key presentations will be available on the Company’s website at https://ir.vorbio.com/news-and-events/events-and-presentations.
About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Investors & Media
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com
Health Journey Addresses 'Best GLP-1 Supplement' Question with Akkermansia-Based Formula Analysis as Six-Month Costs Compare…
A Revolutionary ATCA/VME/VXI 3D-Flow Board: 512 Channels, >2,800 Programmable Operations—Scalable to >50,000 Operations on Each…
After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite…
Boards and executive buyers are raising the 2026 bar for all product and service rankings…
Boards and executive buyers are raising the 2026 bar for all product and service rankings…
Tampa based Celebrity Board-Certified Plastic Surgeon Dr. Meegan Gruber expands an interactive approach that allows…